NASDAQ:AKTS

Aktis Oncology Stock Earnings Reports

etoro logo Buy AKTS
*Your capital is at risk
$24.10
-0.0300 (-0.124%)
At Close: Aug 10, 2026

Aktis Oncology Earnings Calls

Jun 30, 2026
Release date Aug 10, 2026
EPS estimate -$0.440
EPS actual -
Revenue estimate 2.143M
Revenue actual -
Mar 31, 2026
-$0.380 (-22.58%)
Release date May 11, 2026
EPS estimate -$0.310
EPS actual -$0.380
EPS Surprise -22.58%
Revenue estimate 1.93M
Revenue actual 3.227M
Revenue Surprise 67.20%
Dec 31, 2025
-$18.19 (15.76%)
Release date Mar 30, 2026
EPS estimate -$21.59
EPS actual -$18.19
EPS Surprise 15.76%
Revenue estimate 3.281M
Revenue actual 1.87M
Revenue Surprise -43.00%
Sep 30, 2025
-$1.39 (-1,163.64%)
Release date Dec 03, 2025
EPS estimate -$0.110
EPS actual -$1.39
EPS Surprise -1,163.64%
Revenue estimate 12.429M
Revenue actual 4.614M
Revenue Surprise -62.88%

Last 4 Quarters for Aktis Oncology

Below you can see how AKTS performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sep 30, 2025 Missed
Release date Dec 03, 2025
Price on release $
EPS estimate -$0.110
EPS actual -$1.39
EPS surprise -1,163.64%
Date Price
Jan 09, 2026 $22.40
Jan 12, 2026 $21.75
Jan 13, 2026 $21.35
Jan 14, 2026 $20.81
4 days before -100.00%
4 days after 0%
On release day 0%
Change in period -7.10%
Dec 31, 2025 Beat
Release date Mar 30, 2026
Price on release $16.54
EPS estimate -$21.59
EPS actual -$18.19
EPS surprise 15.76%
Date Price
Mar 24, 2026 $18.63
Mar 25, 2026 $18.64
Mar 26, 2026 $17.62
Mar 27, 2026 $15.19
Mar 30, 2026 $16.54
Mar 31, 2026 $17.89
Apr 01, 2026 $17.07
Apr 02, 2026 $17.37
Apr 06, 2026 $16.37
4 days before -11.22%
4 days after -1.03%
On release day 8.16%
Change in period -12.13%
Mar 31, 2026 Missed
Release date May 11, 2026
Price on release $18.27
EPS estimate -$0.310
EPS actual -$0.380
EPS surprise -22.58%
Date Price
May 05, 2026 $19.44
May 06, 2026 $20.03
May 07, 2026 $18.84
May 08, 2026 $18.60
May 11, 2026 $18.27
May 12, 2026 $19.73
May 13, 2026 $19.53
May 14, 2026 $19.50
May 15, 2026 $19.55
4 days before -6.02%
4 days after 7.01%
On release day 7.99%
Change in period 0.566%
Jun 30, 2026
Release date Aug 10, 2026
Price on release $24.10
EPS estimate -$0.440
EPS actual -
Date Price
Aug 04, 2026 $22.84
Aug 05, 2026 $22.65
Aug 06, 2026 $23.44
Aug 07, 2026 $24.13
Aug 10, 2026 $24.10
4 days before 5.52%
4 days after 0%
On release day 0%
Change in period 5.52%

Aktis Oncology Earnings History

Earnings Calendar

FAQ

When is the earnings report for AKTS?
Aktis Oncology, Inc. (AKTS) has scheduled its earnings report for Sep 02, 2026 after the markets close.

What is the AKTS price-to-earnings (P/E) ratio?
AKTS P/E ratio as of Aug 10, 2026 (TTM) is -39.56.

What is the AKTS EPS forecast?
The forecasted EPS (Earnings Per Share) for Aktis Oncology, Inc. (AKTS) for the first fiscal quarter 2025 is -$0.423.

What are Aktis Oncology, Inc.'s retained earnings?
On its balance sheet, Aktis Oncology, Inc. reported retained earnings of $0 for the latest quarter ending Jun 30, 2026.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE